Health care stocks were rising premarket Monday, with The Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) 0.3% higher.
RadNet (RDNT) stock was up more than 7% after the company posted higher Q2 adjusted earnings and service revenue.
Legend Biotech (LEGN) shares were more than 2% higher after the company reported that it swung to Q2 adjusted earnings as revenue increased during the period.
Novartis (NVS) shares were up more than 1% after the company said two phase III trials assessing ianalumab in adults with active Sjogren's disease met the primary endpoint of showing "statistically significant" improvements in disease activity.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。